Cannabist Company Holdings Inc (CBST) - Net Assets
Based on the latest financial reports, Cannabist Company Holdings Inc (CBST) has net assets worth CA$-61.97 Million CAD (≈ $-44.83 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$648.78 Million ≈ $469.32 Million USD) and total liabilities (CA$710.75 Million ≈ $514.15 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CBST financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-61.97 Million |
| % of Total Assets | -9.55% |
| Annual Growth Rate | N/A |
| 5-Year Change | -110.48% |
| 10-Year Change | N/A |
| Growth Volatility | 80.05 |
Cannabist Company Holdings Inc - Net Assets Trend (2018–2024)
This chart illustrates how Cannabist Company Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore CBST total asset value for the complete picture of this company's asset base.
Annual Net Assets for Cannabist Company Holdings Inc (2018–2024)
The table below shows the annual net assets of Cannabist Company Holdings Inc from 2018 to 2024. For live valuation and market cap data, see CBST market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$-30.06 Million ≈ $-21.74 Million |
-146.00% |
| 2023-12-31 | CA$65.35 Million ≈ $47.27 Million |
-68.40% |
| 2022-12-31 | CA$206.81 Million ≈ $149.60 Million |
-62.40% |
| 2021-12-31 | CA$550.08 Million ≈ $397.92 Million |
+91.70% |
| 2020-12-31 | CA$286.95 Million ≈ $207.57 Million |
+7.50% |
| 2019-12-31 | CA$266.93 Million ≈ $193.09 Million |
+27145.69% |
| 2018-12-31 | CA$-986.97K ≈ $-713.96K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cannabist Company Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 118275023200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$1.16 Billion | % |
| Total Equity | CA$-28.69 Million | 100.00% |
Cannabist Company Holdings Inc Competitors by Market Cap
The table below lists competitors of Cannabist Company Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Waja Konsortium Bhd
KLSE:0102
|
$12.60 Million |
|
INVO Fertility, Inc.
NASDAQ:IVF
|
$12.60 Million |
|
Grand Pacific Petrochemical Corp Pref
TW:1312A
|
$12.60 Million |
|
Fitzroy River Corporation Ltd
AU:FZR
|
$12.60 Million |
|
Qyou Media Inc
V:QYOU
|
$12.58 Million |
|
Siam Steel International Public Company Limited
BK:SIAM
|
$12.57 Million |
|
4Imprint Group Plc
LSE:FOUR
|
$12.57 Million |
|
Federal International Holdings Bhd
KLSE:8605
|
$12.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cannabist Company Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 66,529,862 to -28,694,000, a change of -95,223,862 (-143.1%).
- Net loss of 105,886,000 reduced equity.
- Other factors increased equity by 10,662,138.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-105.89 Million | -369.02% |
| Other Changes | CA$10.66 Million | +37.16% |
| Total Change | CA$- | -143.13% |
Book Value vs Market Value Analysis
This analysis compares Cannabist Company Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | CA$0.00 | CA$0.04 | x |
| 2019-12-31 | CA$1.28 | CA$0.04 | x |
| 2020-12-31 | CA$1.32 | CA$0.04 | x |
| 2021-12-31 | CA$1.68 | CA$0.04 | x |
| 2022-12-31 | CA$0.54 | CA$0.04 | x |
| 2023-12-31 | CA$0.17 | CA$0.04 | x |
| 2024-12-31 | CA$-0.06 | CA$0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cannabist Company Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.08%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-78.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -790.95% | 0.00x | 0.00x | CA$-2.65 Million |
| 2019 | -39.13% | -132.44% | 0.20x | 1.50x | CA$-131.80 Million |
| 2020 | -32.87% | -53.36% | 0.26x | 2.37x | CA$-131.53 Million |
| 2021 | -24.86% | -31.10% | 0.33x | 2.41x | CA$-198.90 Million |
| 2022 | -187.40% | -81.32% | 0.49x | 4.66x | CA$-420.84 Million |
| 2023 | -264.11% | -34.36% | 0.62x | 12.37x | CA$-182.36 Million |
| 2024 | 0.00% | -23.08% | 0.66x | 0.00x | CA$-103.02 Million |
Industry Comparison
This section compares Cannabist Company Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $177,045,237
- Average return on equity (ROE) among peers: -55.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cannabist Company Holdings Inc (CBST) | CA$-61.97 Million | 0.00% | N/A | $12.59 Million |
| Aurora Cannabis Inc (ACB) | $430.22K | 0.29% | 0.03x | $197.73 Million |
| Amotiv Limited (AOV) | $886.24 Million | 3.58% | 0.17x | $550.74 Million |
| Aequus Pharmaceuticals Inc (AQS) | $1.68 Million | -166.73% | 0.19x | $479.73K |
| Avicanna Inc (AVCN) | $11.39 Million | -24.98% | 0.87x | $12.72 Million |
| Avant Brands Inc (AVNT) | $134.00K | -18.26% | 0.33x | $4.62 Million |
| Bausch Health Companies Inc (BHC) | $605.00 Million | -92.40% | 50.57x | $2.07 Billion |
| CanadaBis Capital Inc (CANB) | $1.82 Million | -146.97% | 6.29x | $1.53 Million |
| Cipher Pharmaceuticals Inc (CPH) | $10.47 Million | -24.75% | 0.35x | $327.36 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $76.24 Million | -32.43% | 0.15x | $147.03 Million |
About Cannabist Company Holdings Inc
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more